RELZYQ Trademark

Trademark Overview


On Thursday, September 1, 2005, a trademark application was filed for RELZYQ with the United States Patent and Trademark Office. The USPTO has given the RELZYQ trademark a serial number of 78705337. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, April 11, 2007. This trademark is owned by Eli Lilly and Company. The RELZYQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders
relzyq

General Information


Serial Number78705337
Word MarkRELZYQ
Filing DateThursday, September 1, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, April 11, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2006

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 9, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Friday, June 22, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Friday, June 22, 2007ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 10, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 15, 2006ASSIGNED TO EXAMINER
Friday, August 25, 2006EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, May 4, 2006EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 11, 2006PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2006NOTICE OF PUBLICATION
Thursday, February 23, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 17, 2006ASSIGNED TO LIE
Wednesday, February 15, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 9, 2006ASSIGNED TO EXAMINER
Friday, September 9, 2005NEW APPLICATION ENTERED IN TRAM